Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
about
Hepatorenal syndrome: Update on diagnosis and treatmentTreatment and management of ascites and hepatorenal syndrome: an updateRevision and update on clinical practice guideline for liver cirrhosis.Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Treatment of hepatorenal syndrome.A single center experience of combined liver kidney transplantation.Profile and outcome of patients with liver cirrhosis requiring mechanical ventilation.Renal replacement therapy in special settings: extracorporeal support devices in liver failure.Hepatorenal syndrome in the intensive care unit.The challenges of providing renal replacement therapy in decompensated liver cirrhosis.Optimal management of hepatorenal syndrome in patients with cirrhosis.Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunction.Impact of molecular adsorbent recirculating system on renal recovery in type-1 hepatorenal syndrome patients with chronic liver failure.Management of hepatorenal syndrome.Acute kidney injury in acute on chronic liver failure.Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.Kidneys in chronic liver diseases.New Developments in Hepatorenal Syndrome.Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients.Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.
P2860
Q26777608-83CC328D-79F4-4746-B6B8-B7CF34C375D4Q27000268-DB430327-B496-44E6-BC1D-6520A4A8703FQ35890613-20BCCE70-A9B8-4D42-8C8B-C3972B5F1D4CQ36093575-C96C2D2B-849E-464C-9018-A93D2B3BF4E8Q37605883-5A4FEC04-7A32-44F9-8C93-D231432A479AQ37636489-796422E1-2B9A-4A94-8BC0-34F556C3F115Q37857547-B4A2DBF1-10E7-4280-AF67-A4BFCCF161C6Q37868691-8F5EBC5E-377D-46D2-9947-614C32B2A3E4Q37920945-1D6CDABB-8D4E-432F-A068-E6CD5D1BCB61Q37978059-2CA671DB-2134-486E-A4BD-AEC78129CA7CQ38173738-3305AFE1-79C9-46BE-8CE4-F898062F61E2Q38188048-14CE12A1-4954-4C4A-99BE-6EEA1D335749Q38455292-4DCB6FDE-9654-4137-88E1-3C6001440F99Q38463841-B04B7446-DA22-4F4C-9DC8-46284FB42B05Q38608226-6C3C1604-850D-4E46-BA99-4B3B58CF8752Q38654403-AD26D1E0-E498-4648-AA7F-F5B9AE020B38Q39365144-70F1B895-2187-49F8-B7B7-4DE66C114599Q43209206-087CC0F9-9532-40FF-A4E0-18D634400B09Q47807120-6DC716AD-549A-4144-B2BF-3AC345A19E54Q47807373-5878D376-3104-45E0-AB92-55BCFD209B17Q50084092-70AD2FEE-23EF-44F1-94D7-1CBBE8057BC9
P2860
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
description
2004 nî lūn-bûn
@nan
2004 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@ast
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@en
type
label
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@ast
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@en
prefLabel
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@ast
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@en
P2093
P2860
P1476
Which patients benefit from hemodialysis therapy in hepatorenal syndrome?
@en
P2093
Andreas Kribben
Anna Mitchell
Daniel Patschan
Markus Baumann
Oliver Witzke
Susann Patschan
Thomas Philipp
Ulrich Treichel
P2860
P304
P356
10.1111/J.1440-1746.2004.03471.X
P50
P577
2004-12-01T00:00:00Z